246 related articles for article (PubMed ID: 20808948)
21. Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase.
Holder S; Zemskova M; Zhang C; Tabrizizad M; Bremer R; Neidigh JW; Lilly MB
Mol Cancer Ther; 2007 Jan; 6(1):163-72. PubMed ID: 17218638
[TBL] [Abstract][Full Text] [Related]
22. A novel Pim-1 kinase inhibitor targeting residues that bind the substrate peptide.
Tsuganezawa K; Watanabe H; Parker L; Yuki H; Taruya S; Nakagawa Y; Kamei D; Mori M; Ogawa N; Tomabechi Y; Handa N; Honma T; Yokoyama S; Kojima H; Okabe T; Nagano T; Tanaka A
J Mol Biol; 2012 Mar; 417(3):240-52. PubMed ID: 22306408
[TBL] [Abstract][Full Text] [Related]
23. Alkylation of Staurosporine to Derive a Kinase Probe for Fluorescence Applications.
Disney AJ; Kellam B; Dekker LV
ChemMedChem; 2016 May; 11(9):972-9. PubMed ID: 27008372
[TBL] [Abstract][Full Text] [Related]
24. Hit to lead account of the discovery of a new class of inhibitors of Pim kinases and crystallographic studies revealing an unusual kinase binding mode.
Qian K; Wang L; Cywin CL; Farmer BT; Hickey E; Homon C; Jakes S; Kashem MA; Lee G; Leonard S; Li J; Magboo R; Mao W; Pack E; Peng C; Prokopowicz A; Welzel M; Wolak J; Morwick T
J Med Chem; 2009 Apr; 52(7):1814-27. PubMed ID: 19256503
[TBL] [Abstract][Full Text] [Related]
25. Selective bisubstrate inhibitors with sub-nanomolar affinity for protein kinase Pim-1.
Ekambaram R; Enkvist E; Vaasa A; Kasari M; Raidaru G; Knapp S; Uri A
ChemMedChem; 2013 Jun; 8(6):909-13. PubMed ID: 23616352
[TBL] [Abstract][Full Text] [Related]
26. Bundling of microtubules by synapsin 1. Characterization of bundling and interaction of distinct sites in synapsin 1 head and tail domains with different sites in tubulin.
Bennett AF; Baines AJ
Eur J Biochem; 1992 Jun; 206(3):783-92. PubMed ID: 1318836
[TBL] [Abstract][Full Text] [Related]
27. A crystallographic fragment screen identifies cinnamic acid derivatives as starting points for potent Pim-1 inhibitors.
Schulz MN; Fanghänel J; Schäfer M; Badock V; Briem H; Boemer U; Nguyen D; Husemann M; Hillig RC
Acta Crystallogr D Biol Crystallogr; 2011 Mar; 67(Pt 3):156-66. PubMed ID: 21358046
[TBL] [Abstract][Full Text] [Related]
28. Discovery and identification of PIM-1 kinase inhibitors through a hybrid screening approach.
Shao M; Yuan Y; Yu K; Lei K; Zhu G; Chen L; Xiang M
Mol Divers; 2014 May; 18(2):335-44. PubMed ID: 24519385
[TBL] [Abstract][Full Text] [Related]
29. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
[TBL] [Abstract][Full Text] [Related]
30. Heteroaromatic Pim Kinase Inhibitors Containing a Pyrazole Moiety.
Moreau P; Anizon F; Giraud F; Esvan YJ
Recent Pat Anticancer Drug Discov; 2016; 11(3):309-21. PubMed ID: 27194556
[TBL] [Abstract][Full Text] [Related]
31. Aminothiazolones as potent, selective and cell active inhibitors of the PIM kinase family.
Quevedo CE; Bataille CJR; Byrne S; Durbin M; Elkins J; Guillermo A; Jones AM; Knapp S; Nadali A; Walker RG; Wilkinson IVL; Wynne GM; Davies SG; Russell AJ
Bioorg Med Chem; 2020 Nov; 28(22):115724. PubMed ID: 33128909
[TBL] [Abstract][Full Text] [Related]
32. New Quinoxaline Derivatives as Dual Pim-1/2 Kinase Inhibitors: Design, Synthesis and Biological Evaluation.
Oyallon B; Brachet-Botineau M; Logé C; Robert T; Bach S; Ibrahim S; Raoul W; Croix C; Berthelot P; Guillon J; Pinaud N; Gouilleux F; Viaud-Massuard MC; Denevault-Sabourin C
Molecules; 2021 Feb; 26(4):. PubMed ID: 33562106
[TBL] [Abstract][Full Text] [Related]
33. Kinase crystal identification and ATP-competitive inhibitor screening using the fluorescent ligand SKF86002.
Parker LJ; Taruya S; Tsuganezawa K; Ogawa N; Mikuni J; Honda K; Tomabechi Y; Handa N; Shirouzu M; Yokoyama S; Tanaka A
Acta Crystallogr D Biol Crystallogr; 2014 Feb; 70(Pt 2):392-404. PubMed ID: 24531473
[TBL] [Abstract][Full Text] [Related]
34. Development of organometallic S6K1 inhibitors.
Qin J; Rajaratnam R; Feng L; Salami J; Barber-Rotenberg JS; Domsic J; Reyes-Uribe P; Liu H; Dang W; Berger SL; Villanueva J; Meggers E; Marmorstein R
J Med Chem; 2015 Jan; 58(1):305-14. PubMed ID: 25356520
[TBL] [Abstract][Full Text] [Related]
35. Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors.
Pettus LH; Andrews KL; Booker SK; Chen J; Cee VJ; Chavez F; Chen Y; Eastwood H; Guerrero N; Herberich B; Hickman D; Lanman BA; Laszlo J; Lee MR; Lipford JR; Mattson B; Mohr C; Nguyen Y; Norman MH; Powers D; Reed AB; Rex K; Sastri C; Tamayo N; Wang P; Winston JT; Wu B; Wu T; Wurz RP; Xu Y; Zhou Y; Tasker AS; Wang HL
J Med Chem; 2016 Jul; 59(13):6407-30. PubMed ID: 27285051
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of PIM-1 kinase: a computational analysis of the binding free energies of a range of imidazo [1,2-b] pyridazines.
Doudou S; Sharma R; Henchman RH; Sheppard DW; Burton NA
J Chem Inf Model; 2010 Mar; 50(3):368-79. PubMed ID: 20175582
[TBL] [Abstract][Full Text] [Related]
37. Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors.
Olla S; Manetti F; Crespan E; Maga G; Angelucci A; Schenone S; Bologna M; Botta M
Bioorg Med Chem Lett; 2009 Mar; 19(5):1512-6. PubMed ID: 19179076
[TBL] [Abstract][Full Text] [Related]
38. What doesn't fit is made to fit: Pim-1 kinase adapts to the configuration of stilbene-based inhibitors.
Hochban PMM; Heyder L; Heine A; Diederich WE
Arch Pharm (Weinheim); 2024 Jun; 357(6):e2400094. PubMed ID: 38631036
[TBL] [Abstract][Full Text] [Related]
39. Kinase selectivity potential for inhibitors targeting the ATP binding site: a network analysis.
Huang D; Zhou T; Lafleur K; Nevado C; Caflisch A
Bioinformatics; 2010 Jan; 26(2):198-204. PubMed ID: 19942586
[TBL] [Abstract][Full Text] [Related]
40. New potent and selective inhibitor of Pim-1/3 protein kinases sensitizes human colon carcinoma cells to doxorubicin.
Moreau P; Dezhenkova LG; Anizon F; Nauton L; Thery V; Liang S; Kaluzhny DN; Shtil AA
Anticancer Agents Med Chem; 2014; 14(9):1228-36. PubMed ID: 25175798
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
